[1] 王清任.医林改错[M].北京:中国医药科技出版社,2011:28. Wang QR. Correction of Errors in Medical Works[M]. Beijing: China Medical Science Press, 2011:28. [2] 张兴宏.加味血府逐瘀汤治疗非酒精性脂肪肝疗效分析[J].中华中医药学刊,2012,30(10):2356-2357. Zhang XH. Clinical efficacy of treatment of non-alcoholic steatohepatitis by modified Xuefu Zhuyu Decoction[J]. Chinese Archives of Traditional Chinese Medicine, 2012,30(10):2356-2357. [3] 任常胜,程振芳.论引经药在方剂中的应用[J].内蒙古中医药,2002,21(6):33. Ren CS, Cheng ZF. Discussion on the application of medicinal drugs in prescription[J]. Nei Mongol Journal of Traditional Chinese Medicine, 2002,21(6):33. [4] Guo H, Diao N, Yuan R, et al. Subclinical-dose endotoxin sustains low-grade inflammation and exacerbates steatohepatitis in high-fat diet-fed mice[J]. Immunol, 2016,196(5):2300-2308. [5] 陈奇.中药药理研究方法学[M].2版.北京:人民卫生出版社, 2006:1167-1170. Chen Q. Research Methodology of Pharmacology of Chinese Materia Medica (2nd ed.)[M]. Beijing: People's Medical Publishing House, 2006:1167-1170. [6] 黄巍,熊伟,唐灿,等.血府逐瘀汤中桔梗和牛膝对芍药苷组织分布的影响[J].中国实验方剂学杂志,2015,21(18):85-88. Huang W, Xiong W, Tang C, et al. Influence of platyodonis radix and achyranthis bidentatae radix in Xuefu Zhuyu decoction on tissue distribution of paeoniflorin[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2015,21(18):85-88. [7] 陈剑明,张声生,郭前坤,等.芍药苷对非酒精性脂肪肝大鼠模型的疗效与保护机制研究[J].中华中医药杂志,2013,28(5):1376-1381. Chen JM, Zhang SS, Guo QK, et al. Study on the efficacy and protective mechanism of paeoniflorin on the rat model of nonalcoholic fatty liver[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2013,28(5):1376-1381. [8] Li Z, Xue J, Chen P, et al. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies[J]. Gastroenterol Hepatol, 2014,29(1):42-51. [9] 李军祥,陈润花,苏冬梅,等.中医药治疗非酒精性脂肪性肝病研究述评[J].世界华人消化杂志,2010,18(14):1443-1451. Li JX, Chen RH, Su DM, et al. Advances in management of nonalcoholic fatty liver disease by Chinese medicine[J]. World Chinese Journal of Digestology, 2010,18(14):1443-1451. [10] 董桂芬.血府逐瘀汤加减治疗非酒精性脂肪肝50例[J].光明中医,2013,28(6):1151-1152. Dong GF. 50 cases of non-alcoholic fatty liver treated with Xuefu Zhuyu Decoction[J]. Guangming Journal of Chinese Medicine, 2013,28(6):1151-1152. [11] 宋丽,唐宋琪,童继威,等.血府逐瘀汤防治非酒精性脂肪肝的效应机制研究[J].中国中西医结合杂志,2020,40(9):1103-1106. Song L,Tang SQ,Tong JW, et al. Study on the mechanism of Xuefu Zhuyu Decoction in preventing and treating NAFLD[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2020,40(9):1103-1106. [12] Lee PY, Wang JX, Parisini E, et al. Ly6 family proteins in neutrophil biology[J]. J Leukoc Biol, 2013,94(4):585-594. [13] Rich J, Lee JC. The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse[J]. Diabetes, 2005,54(10):2904-2910. [14] Shalkami AS, Hassan M, Bakr AG. Antioxidant and anti-apoptotic activity of diosmin in acetic acid-induced ulcerative colitis[J]. Hum Exp Toxicol, 2018,37(1):78-86. |